Application processes at NIH are changing. Applicant organizations are encouraged to start preparing for this transtion by registering with Grants.gov and NIH eRA Commons now. |
PHS 2007-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent
SBIR [R43/R44])
Release Date: January 16, 2007
Announcement Number: PA-07-280
Application Receipt Date:
April 5, 2007
August 5, 2007
December 5, 2007
Funding Contact: Randall Stewart, Ph.D.
Program Area: Channels, Synapses and Neural Circuits
Brief Description:
The SBIR program is structured in three phases, the first two of which are supported using SBIR funds. The objective of Phase
I is to establish the technical/scientific merit and feasibility of the proposed R/R&D efforts. The objective of Phase II
is to continue the research or R&D efforts initiated in Phase I. An objective of the SBIR program is to increase private sector
commercialization of innovations derived from Federal R/R&D. The objective of Phase III, where appropriate, is for the SBC
to pursue with non-SBIR funds (either Federal or non-Federal) the commercialization objectives resulting from the results
of the R/R&D funded in Phases I and II. In some Federal agencies, Phase III may involve follow-on, non-SBIR funded R&D, or
production contracts for products or processes intended for use by the U.S. Government.
Choose an option to view additional funding announcements |
New Announcements | Research Area | RFAs Only | PAs Only | RFPs Only | Notices Only | Supplements Only | All Announcements | Archives |